% Generated by roxygen2: do not edit by hand
% Please edit documentation in R/adaptivetrialdesign.h.R
\name{adaptivetrialdesign}
\alias{adaptivetrialdesign}
\title{Adaptive Trial Design Methods}
\usage{
adaptivetrialdesign(
  data,
  outcome,
  treatment,
  outcomeLevel,
  stratification_variables = NULL,
  time_variable = NULL,
  adaptation_type = "sample_size",
  design_framework = "bayesian",
  interim_analysis = TRUE,
  interim_timing = "information",
  interim_fractions = "0.25,0.50,0.75",
  max_interim_analyses = 3,
  efficacy_boundary = 0.95,
  futility_boundary = 0.1,
  boundary_type = "obrien_fleming",
  planned_sample_size = 100,
  minimum_effect_size = 0.5,
  target_power = 0.8,
  type1_error_rate = 0.05,
  max_sample_size_inflation = 2,
  prior_type = "weakly_informative",
  historical_data_weight = 0.1,
  prior_parameters = "",
  decision_criterion = "posterior_probability",
  bayes_factor_threshold = 3,
  predictive_power_threshold = 0.8,
  run_simulations = TRUE,
  n_simulations = 1000,
  true_effect_scenarios = "0,0.3,0.5,0.8",
  mcmc_samples = 5000,
  mcmc_burnin = 2000,
  mcmc_chains = 3,
  show_design_summary = TRUE,
  show_interim_results = TRUE,
  show_stopping_boundaries = TRUE,
  show_sample_size_evolution = TRUE,
  show_operating_characteristics = TRUE,
  show_posterior_evolution = TRUE,
  show_decision_analysis = TRUE,
  show_interpretation = TRUE,
  alpha_spending_function = "obf_type",
  spending_parameter = 1,
  blinded_sample_size_reestimation = FALSE,
  conditional_power_threshold = 0.2,
  clinical_context = "general",
  set_seed = TRUE,
  seed_value = 42,
  regulatory_framework = "general",
  dmb_recommendations = TRUE
)
}
\arguments{
\item{data}{The data as a data frame for adaptive trial design analysis.}

\item{outcome}{.}

\item{treatment}{.}

\item{outcomeLevel}{.}

\item{stratification_variables}{.}

\item{time_variable}{For time-to-event endpoints}

\item{adaptation_type}{.}

\item{design_framework}{.}

\item{interim_analysis}{.}

\item{interim_timing}{.}

\item{interim_fractions}{Comma-separated fractions of planned
information/sample size}

\item{max_interim_analyses}{.}

\item{efficacy_boundary}{Posterior probability threshold for efficacy
stopping}

\item{futility_boundary}{Posterior probability threshold for futility
stopping}

\item{boundary_type}{.}

\item{planned_sample_size}{.}

\item{minimum_effect_size}{Standardized or raw effect size}

\item{target_power}{.}

\item{type1_error_rate}{.}

\item{max_sample_size_inflation}{Maximum fold increase from planned sample
size}

\item{prior_type}{.}

\item{historical_data_weight}{Weight given to historical data in
informative priors}

\item{prior_parameters}{Comma-separated prior parameters (mean,sd for
normal)}

\item{decision_criterion}{.}

\item{bayes_factor_threshold}{.}

\item{predictive_power_threshold}{.}

\item{run_simulations}{.}

\item{n_simulations}{.}

\item{true_effect_scenarios}{Comma-separated effect sizes for simulation}

\item{mcmc_samples}{.}

\item{mcmc_burnin}{.}

\item{mcmc_chains}{.}

\item{show_design_summary}{.}

\item{show_interim_results}{.}

\item{show_stopping_boundaries}{.}

\item{show_sample_size_evolution}{.}

\item{show_operating_characteristics}{.}

\item{show_posterior_evolution}{.}

\item{show_decision_analysis}{.}

\item{show_interpretation}{.}

\item{alpha_spending_function}{.}

\item{spending_parameter}{.}

\item{blinded_sample_size_reestimation}{.}

\item{conditional_power_threshold}{.}

\item{clinical_context}{.}

\item{set_seed}{.}

\item{seed_value}{.}

\item{regulatory_framework}{.}

\item{dmb_recommendations}{Generate templates for Data Monitoring Board
recommendations}
}
\value{
A results object containing:
\tabular{llllll}{
\code{results$designSummary} \tab \tab \tab \tab \tab a table \cr
\code{results$interimResults} \tab \tab \tab \tab \tab a table \cr
\code{results$stoppingBoundaries} \tab \tab \tab \tab \tab a table \cr
\code{results$sampleSizeEvolution} \tab \tab \tab \tab \tab a table \cr
\code{results$operatingCharacteristics} \tab \tab \tab \tab \tab a table \cr
\code{results$posteriorEvolution} \tab \tab \tab \tab \tab a table \cr
\code{results$decisionAnalysis} \tab \tab \tab \tab \tab a table \cr
\code{results$bayesFactors} \tab \tab \tab \tab \tab a table \cr
\code{results$predictivePower} \tab \tab \tab \tab \tab a table \cr
\code{results$regulatoryConsiderations} \tab \tab \tab \tab \tab a table \cr
\code{results$dmbRecommendations} \tab \tab \tab \tab \tab a table \cr
\code{results$clinicalInterpretation} \tab \tab \tab \tab \tab a html \cr
\code{results$methodsExplanation} \tab \tab \tab \tab \tab a html \cr
\code{results$stoppingBoundaryPlot} \tab \tab \tab \tab \tab an image \cr
\code{results$sampleSizeEvolutionPlot} \tab \tab \tab \tab \tab an image \cr
\code{results$posteriorEvolutionPlot} \tab \tab \tab \tab \tab an image \cr
\code{results$operatingCharacteristicsPlot} \tab \tab \tab \tab \tab an image \cr
\code{results$decisionAnalysisPlot} \tab \tab \tab \tab \tab an image \cr
\code{results$predictivePowerPlot} \tab \tab \tab \tab \tab an image \cr
}

Tables can be converted to data frames with \code{asDF} or \code{\link{as.data.frame}}. For example:

\code{results$designSummary$asDF}

\code{as.data.frame(results$designSummary)}
}
\description{
Advanced adaptive trial design methods for clinical research including
Bayesian interim analysis, adaptive sample size re-estimation, futility
stopping rules, and group sequential designs. Designed for efficient
clinical trial conduct with ethical early stopping capabilities.
}
\examples{
# Adaptive trial design with interim analysis
adaptivetrialdesign(
    data = trial_data,
    outcome = "response",
    treatment = "arm",
    adaptation_type = "sample_size",
    interim_analysis = TRUE,
    futility_boundary = 0.1
)

}
